Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Embecta Corp. (EMBC : NSDQ)

• Company Description    Embecta Corp. is a pure-play diabetes care company. Embecta is based in FRANKLIN LAKES, N.J. Number of Employees: 1,850

• Price / Volume Information    Yesterday's Closing Price: $5.80 Daily Weekly Monthly 20 Day Moving Average: 1,440,521 shares Shares Outstanding: 56.66 (millions) Market Capitalization: $328.63 (millions) Beta: 0.86 52 Week High: $15.55 52 Week Low: $2.77 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 16.23% 16.75% 12 Week 85.30% 81.36% Year To Date -51.18% -56.70%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 300 Kimball Drive Suite 300 - Parsippany,NJ 07054 USA ph: 862-401-0000 fax: - investor.relations@embecta.com http://www.embecta.com

• General Corporate Information    Officers Devdatt Kurdikar - President and Chief Executive Officer David F. Melcher - Chairman of the Board and Director Jacob Elguicze - Senior Vice President; Chief Financial Officer Carrie L. Anderson - Director Claire Pomeroy - Director Peer Information Embecta Corp. (CHCR) Embecta Corp. (ESRX) Embecta Corp. (MYDP) Embecta Corp. (COR) Embecta Corp. (GBCS) Embecta Corp. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 29082K105 SIC: 3841 Fiscal Year Fiscal Year End: September Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/24/26 Share - Related Items Shares Outstanding: 56.66 Most Recent Split Date: (:1) Beta: 0.86 Market Capitalization: $328.63 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.69% Current Fiscal Quarter EPS Consensus Estimate: $0.31 Indicated Annual Dividend: $0.04 Current Fiscal Year EPS Consensus Estimate: $1.84 Payout Ratio: 0.02 Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: -0.18 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 08/27/2026 - $0.01 Next EPS Report Date: 11/24/26

• Fundamental Ratios P/E Current FY Estimate: 3.16 Trailing 12 Months: 2.84 PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: 1.45 Price / Sales: 0.32 EPS Growth vs. Year Ago Period: -50.00% vs. Previous Quarter: 107.41% Sales Growth vs. Year Ago Period: -8.05% vs. Previous Quarter: 22.50% ROE 06/30/26 - -19.25 03/31/26 - -23.96 12/31/25 - -26.66 ROA 06/30/26 - 10.82 03/31/26 - 14.12 12/31/25 - 16.06 Current Ratio 06/30/26 - 1.68 03/31/26 - 2.46 12/31/25 - 2.64 Quick Ratio 06/30/26 - 1.17 03/31/26 - 1.68 12/31/25 - 1.87 Operating Margin 06/30/26 - 11.82 03/31/26 - 14.70 12/31/25 - 16.48 Net Margin 06/30/26 - 8.59 03/31/26 - 10.73 12/31/25 - 12.92 Pre-Tax Margin 06/30/26 - 12.27 03/31/26 - 16.27 12/31/25 - 18.14 Book Value 06/30/26 - -10.33 03/31/26 - -10.55 12/31/25 - -10.35 Inventory Turnover 06/30/26 - 2.18 03/31/26 - 2.14 12/31/25 - 2.21 Debt-to-Equity 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Capital 06/30/26 - - 03/31/26 - - 12/31/25 - -

Powered by Zacks Investment Research ©